# Lidocaine Versus ESP - After Bariatric Surgery

> **NCT05700214** · NA · COMPLETED · sponsor: **Jagiellonian University** · enrollment: 279 (actual)

## Conditions studied

- Anesthetics
- Local Anesthetics

## Interventions

- **DRUG:** Ropivacaine injection
- **DRUG:** Lidocaine IV

## Key facts

- **NCT ID:** NCT05700214
- **Lead sponsor:** Jagiellonian University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 279 (ACTUAL)
- **Last updated:** 2025-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05700214

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05700214, "Lidocaine Versus ESP - After Bariatric Surgery". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05700214. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*